These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28411056)

  • 1. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
    Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
    Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanoparticles (SLN & NLC) for delivery of vitamin E: a comprehensive review.
    Saez V; Souza IDL; Mansur CRE
    Int J Cosmet Sci; 2018 Apr; 40(2):103-116. PubMed ID: 29505675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
    Frias I; Neves AR; Pinheiro M; Reis S
    Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
    Suter F; Schmid D; Wandrey F; Zülli F
    Eur J Pharm Biopharm; 2016 Nov; 108():304-309. PubMed ID: 27343822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
    Ramesh N; Mandal AKA
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
    Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
    Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
    Neves AR; Lúcio M; Martins S; Lima JL; Reis S
    Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
    Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
    Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLN and NLC for topical, dermal, and transdermal drug delivery.
    Souto EB; Baldim I; Oliveira WP; Rao R; Yadav N; Gama FM; Mahant S
    Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of the Effect of Different Emulsifiers on the Transdermal Delivery of EGCG Entrapped in a Polymeric Micelle System.
    Casiraghi A; Franzè S; Selmin F; Dazio V; Minghetti P
    Planta Med; 2017 Mar; 83(5):405-411. PubMed ID: 27286328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
    Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
    Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.
    Lucia M
    Curr Drug Metab; 2017; 18(5):469-480. PubMed ID: 28228079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
    Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.
    Shrotriya SN; Ranpise NS; Vidhate BV
    Drug Deliv Transl Res; 2017 Feb; 7(1):37-52. PubMed ID: 27981502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
    Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.